Denver Infectious Disease Consultants, PLLC
Quick facts
Marketed products
- Raltegravir and Abacavir/Lamivudine · Infectious Disease / Virology
This combination inhibits HIV replication by blocking integrase (raltegravir) and reverse transcriptase (abacavir/lamivudine) at different stages of the viral lifecycle.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: